Agility Life Sciences is an award-winning formulation development CDMO, with a global client base ranging from spin-outs to multinational organisations. We use our “Fast Futureproof Formulations” approach to give our Clients’ badly behaved molecules the best chance of success in preclinical studies and enable them to be accelerated to clinic or commercialisation. Our formulations specialisms include oral, ocular, intravenous, intranasal, topical and subcutaneous products. We develop and manufacture formulations to meet the needs of our clients including:

Overcoming solubility and permeability issues

Immediate, controlled and sustained release

Formulations and analytical methods suitable for preclinical safety and efficacy studies, including GLP tox studies

Clinical and commercial prototypes

Reverse engineering of existing products

Contact us at claire.thompson@agilitylifesciences.com to find out how we can help accelerate your milestones and futureproof your products.